⌕
Bausch Health Companies · BHC · NYSE
Tenet 51 · Mixed
Compare
$8.42+0.84%At closeTenet 51 · Mixed
$8.42+0.07 (+0.84%)
At close: Nov 16, 2026, 4:00 PM ET· NYSE · USD

Bausch Health Companies (BHC) Stock Checks

How BHC measures up against value, income, timing, and long-hold tenets. Every criterion shows the number as of the last close and the pass rule. Always free.

Sources Company filings and computed by Tenet Filings and TenetScreens as of How we compute thisNot investment advice

The tenets below and the 0-100 Tenet Score on this report are two separate computations: each tenet runs its own criteria and its own pass rule, while the score is a percentile composite reported as one of four verdict words (Strong, Solid, Mixed or Weak).

0 / 17 qualify todayas of close, Nov 13, 2026 · computed nightly from our fundamentals DB; point-in-time auditable.
QUALIFIES
0
meet every gate today
BORDERLINE
3
within one input of the gate
FAILS
5
miss at least one gate
UNKNOWN
9
insufficient data to judge
Buffett Qualitydurable moat
~ Borderline
Unknown — no dataROE ≥ 15%— · ≥ 15.0%
PassesGross margin ≥ 40%72.6% · ≥ 40.0%
FailsNet margin ≥ 15%−7.5% · ≥ 15.0%
Unknown — no dataDebt/equity ≤ 0.5— · ≤ 0.50
PassesGrowing FCF (multi-yr)4.4% · > 0
Decided by the pass rule for Buffett Quality.
The pass rule for Buffett Quality is what decides that verdict, and it is not restated here. 2 of 5 carry no data.Buffett Quality under The screens ›Today's Buffett Quality list ›
PassesReturn on assets positive0.5% · > 0
PassesOperating cash flow positive$1.4B · > 0
PassesReturn on assets improving−0.3% → 0.5%
PassesEarnings backed by cash (CFO > net income)$1.4B vs $120.0M
FailsLeverage falling (long-term debt / assets)71.4% → 78.1%
PassesCurrent ratio improving0.86 → 1.47
PassesNo share dilution (≤ +2%)+1.9%
FailsGross margin expanding71.1% → 70.7%
PassesAsset turnover improving0.36 → 0.39
Decided by the pass rule for Piotroski F-Score.
The pass rule for Piotroski F-Score is what decides that verdict, and it is not restated here.Piotroski F-Score under The screens ›Today's Piotroski F-Score list ›
FailsROIC ≥ 15%6.1% · ≥ 15.0%
FailsNet debt/EBITDA ≤ 3×7.3× · ≤ 3.0×
FailsAltman Z ≥ 3 (safe zone)0.22 · ≥ 3.00
Decided by the pass rule for Munger Compounders.
The pass rule for Munger Compounders is what decides that verdict, and it is not restated here.Munger Compounders under The screens ›Today's Munger Compounders list ›
PassesEBIT > 0$1.2B · > 0
FailsEarnings yield EBIT/EV ≥ 6%5.6% · ≥ 6.0%
PassesReturn on capital ≥ 25%26.2% · ≥ 25.0%
Decided by the pass rule for Magic Formula.
The pass rule for Magic Formula is what decides that verdict, and it is not published separately on the methodology page.About this screen ›Today's Magic Formula® list ›
PassesSize: market cap ≥ $2B$3.1B · ≥ $2.0B
FailsCurrent ratio ≥ 21.56 · ≥ 2.00
FailsPositive EPS 9yWe hold no record of earnings per share or net income for fiscal 2020, so that year is left out and this test covers the 9 fiscal years we can judge.2y
FailsPays a dividend$0.00 · > 0
Unknown — no dataEPS growth ≥ 3%/yr— · ≥ 3.0%
Unknown — no dataP/E ≤ 15— · ≤ 15.00
Unknown — no dataP/E × P/B ≤ 22.5— · ≤ 22.50
Decided by the pass rule for Graham Defensive.
The pass rule for Graham Defensive is what decides that verdict, and it is not restated here. 3 of 7 carry no data.Graham Defensive under The screens ›Today's Graham Defensive list ›
Unknown — no dataPEG < 1 (hist. growth)— · < 1.00
Unknown — no dataEPS growth 10–30%— · 10.0%–30.0%
Verdict Unknown for this set.
Verdict Unknown for this set. None of the 2 checks below carry data.Lynch GARP under The screens ›Today's Lynch GARP list ›
FailsPays a dividend$0.00 · > 0
Unknown — no dataYield in a healthy band (not a yield trap)— · 1.0%–8.0%
Unknown — no dataCovered by free cash flow— · ≥ 1.20
Unknown — no dataEarnings payout not stretched— · ≤ 75.0%
Unknown — no dataBalance sheet can sustain the payout7.3× · ≤ 4.0×
Unknown — no dataAnnual dividend raised 10+ years running (Aristocrat ≥25, King ≥50)0.00 · ≥ 10.00
Unknown — no dataNo dividend cut in the last 5 years—
Unknown — no data5-year dividend growth ≥ 5%/yr— · ≥ 5.0%
Verdict Unknown for this set.
Verdict Unknown for this set. 1 of 8 checks below carry data. The pass rule for Income & Dividend Safety is not published separately on the methodology page.
FailsPays a dividend$0.00 · > 0
Unknown — no dataAnnual dividend raised 10+ years running (Aristocrat ≥25, King ≥50)— · ≥ 10.00
Unknown — no dataNo dividend cut in the last 5 years—
Unknown — no data5-year dividend growth ≥ 5%/yr— · ≥ 5.0%
Unknown — no dataCovered by free cash flow— · ≥ 1.20
Unknown — no dataPayout not stretched— · ≤ 75.0%
Verdict Unknown for this set.
Verdict Unknown for this set. 1 of 6 checks below carry data.Dividend Growth under The screens ›Today's Dividend Growth list ›
FailsReturn on invested capital ≥ 15% in 4+ of the last 5 years0 of 5
Not scored: see the reason belowRevenue compounding ≥ 8%/yr over 5 yearsFive-year revenue history is incomplete in our data, so the compounding rate can't be computed yet.— · ≥ 8.0%
FailsNot diluting: diluted share count flat-to-down (≤ +1%/yr)1.1% · ≤ 1.0%
PassesFree cash flow margin ≥ 12%16.8% · ≥ 12.0%
Not scored: see the reason belowEarnings backed by cash (operating cash flow ≥ net income)A loss year makes cash-vs-earnings unreadable: the ratio inverts over negative net income, so it is not scored (never counted against).— · ≥ 1.00
Reading: does not hold. Not a gate checkDisciplined buybacks: actively reducing the share count (bonus)reading, not a gate check1.1%
Decided by the pass rule for Quality Compounder.
The pass rule for Quality Compounder is what decides that verdict, and it is not restated here. 2 of 5 carry no data. Lines marked as readings are published beside the checks and are not gate checks.Quality Compounder under The screens ›Today's Quality Compounder list ›
Unknown — no dataOff its 52-week high by 8–35% (a dip, not a collapse)— · 8.0%–35.0%
Unknown — no dataDip within its own normal pullback band—
Unknown — no dataNot past where its dips have historically recovered from—
Unknown — no dataA dip in an uptrend (above a rising 200-day)—
Unknown — no dataHigher-low structure still intact—
Unknown — no dataClear of the earnings blackout (more than 5 days out)— · > 5.00
Verdict Unknown for this set.
Verdict Unknown for this set. None of the 6 checks below carry data. The pass rule for Drawdown Context is not published separately on the methodology page.
Unknown — no dataA bullish MACD cross within 10 sessions— · ≤ 10.00
Unknown — no dataReclaimed a rising 50-day EMA—
Unknown — no dataPrinted a higher low—
PassesA volume thrust on the turn (≥ 1.2× normal)1.43 · ≥ 1.20
FailsReversal signals fired: 3 of 4 (MACD·MA·HL·Vol)1.00 · ≥ 3.00
Decided by the pass rule for Reversal Evidence.
The pass rule for Reversal Evidence is what decides that verdict, and it is not published separately on the methodology page. 3 of 5 carry no data.
Unknown — no dataIn the cheap half of its own 5-year valuation range—
Not scored: see the reason belowEarnings estimates not being cutNo analyst estimate revisions are on file for this company yet, so there is nothing to read a trend from.—
PassesReturns on capital not deteriorating0.03
Verdict Unknown for this set.
Verdict Unknown for this set. 1 of 3 checks below carry data. The pass rule for Not-a-Value-Trap Gate is not published separately on the methodology page.
PassesOperating profit is positive$1.2B · > 0
FailsReturn on invested capital ≥ 10%6.1% · ≥ 10.0%
FailsA solvent balance sheet (Altman Z ≥ 1.8, net debt/EBITDA ≤ 4)0.2×
PassesQuality score ≥ 5050.10 · ≥ 50.00
Unknown — no dataRevenue growing over 5 years— · > 0
Decided by the pass rule for Quality Floor.
The pass rule for Quality Floor is what decides that verdict, and it is not published separately on the methodology page. 1 of 5 carry no data.
A research signal from published criteria, not a recommendation.
Unknown — no dataDrawdown context—
FailsReversal evidence1 of 4 signals fired
Unknown — no dataTrap gate1 of 3 held · 2 no data
FailsQuality floor2 of 5 held · 1 no data
Invalidation level (structure break) not yet computable—
Verdict Unknown for this set.
Verdict Unknown for this set. No price factors yet: the timing receipts populate after the nightly engine runs.Qualified Dip under The screens ›Today's Qualified Dip list ›
Unknown — no dataTrading above its 50-day average—
Unknown — no dataTrading above its 200-day average—
Unknown — no data50-day average above the 200-day (uptrend stack)—
Unknown — no data50-day average sloping up— · > 0
Verdict Unknown for this set.
Verdict Unknown for this set. None of the 4 checks below carry data. The pass rule for Trend Alignment is not published separately on the methodology page.
Unknown — no data3-month return in the top half of the universe— · ≥ 0.50
Unknown — no data12-minus-1 momentum in the top half of the universe— · ≥ 0.50
Unknown — no dataRelative strength vs the S&P 500 improving— · > 0
Not scored: see the reason belowEarnings estimates being revised upNo analyst estimate revisions are on file for this company yet, so there is nothing to read a trend from.—
Verdict Unknown for this set.
Verdict Unknown for this set. None of the 4 checks below carry data. The pass rule for Relative Strength is not published separately on the methodology page.
Unknown — no dataMACD above its signal line—
Not scored: see the reason belowBack above the 50-day on a fresh cross (≤10 sessions)This is a two-part reading (price back above the 50-day, and a bullish momentum cross inside 10 sessions) and the 50-day average is not on record for this name yet, so it is left unscored rather than counted either way.—
Unknown — no dataHigher high and higher low (stair-stepping up)—
PassesA volume thrust on the move (≥ 1.2× normal)1.43 · ≥ 1.20
Verdict Unknown for this set.
Verdict Unknown for this set. 1 of 4 checks below carry data. The pass rule for Momentum Trigger is not published separately on the methodology page.
Average daily swing: high0.06
Volatility band width—
Distance from its 52-week high—
Every verdict is auditableEach criterion shows the number as of the last close and the pass rule side by side: a receipt, not a rating. Several of these screens publish their rule in full under The screens; each row links to its own section where there is one.
Unknown ≠ failAn “— Unknown” verdict means the inputs were insufficient: context, not a signal, and never counted as a fail.

How many investing rule sets does Bausch Health Companies pass?

Bausch Health Companies qualifies on 0 of 17 rule sets as of 2026-11-13, with 3 borderline and 5 failing.

Does Bausch Health Companies meet the Graham Defensive criteria?

Bausch Health Companies fails the Graham Defensive rule set as of 2026-11-13.

Does Bausch Health Companies meet the Buffett Quality criteria?

Bausch Health Companies is borderline on the Buffett Quality rule set as of 2026-11-13.

Computed from our fundamentals DB; historical-CAGR PEG basis for Lynch. Research, not investment advice. Tenet's rulesets are independently developed from publicly available sources, and Tenet is not affiliated with, sponsored by, endorsed by or otherwise associated with any referenced investor or trademark owner. Full notice. MAGIC FORMULA is a trademark of MagicFormulaInvesting.com LLC.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.